The Effect of Naltrexone and Varenicline on Alcohol-Mediated Smoking Lapse
What is the purpose of this trial?
The purpose of this study is to examine how medications thought to attenuate the effects of alcohol (naltrexone) and smoking cessation medications (varenicline) affect the ability to resist smoking and also subsequent ad-lib smoking, following a low-dose alcohol priming drink, in non-treatment seeking alcohol-drinking daily smokers.
- 21 Years - 55 Years
- Yale University
- January 2008
- Last Updated:
- October 7, 2014
- Study HIC#:
Clinicaltrials.gov ID: NCT00773422